drugset / Trial / NCT05265910
A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a single-center, randomized, double-masked, parallel study. In this clinical study, the efficacy comparison between Pataday® Once Daily Relief Extra Strength and Claritin® Tablets 24-Hour will be made using the Ora-CAC model, a validated clinical model accepted by regulatory agents for assessing the efficacy of products on the signs and symptoms of allergic conjunctivitis.
Timeline
- Start
- 2021-12-14
- Primary completion
- 2022-04-23
- Completion
- 2022-04-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Loratadine | Small molecule | 10 mg | Oral |
| Comparator | Olopatadine | Other / unclassified | 0.7 % | Other |
| Comparator | Tears Naturale | Unknown | — | — |